Langham Hall is pleased to announce that it has supported Northcote Equity in the successful first and final close of its second fund, Northcote Fund II LP (“Fund II”), at its hard cap of £250 million. The close comes less than two years after Northcote Equity's debut fund, Northcote Fund I, reached its hard cap of £160 million.

As with its first fund, Fund II will invest in founder-owned businesses in the lower mid-market across the UK and Ireland, with a focus on the technology and business services sectors. The fund will target equity investments of between £10 million and £40 million per transaction, taking both majority and minority positions.

Founded in 2025 by Matthew Charman, Scott Fairlie and Charles Dale, Northcote Equity brings together a team with a decade of shared experience. Fund II has attracted capital from leading institutional investors, including university endowments and family offices across the US and Europe.  Alongside a handful of new LPs, Fund I investors have committed more than 100% of their Fund I capital to Fund II, reflecting their confidence in Northcote’s progress.

Langham Hall has supported Northcote Equity since launch and continues to provide fund administration and accounting services from its Guernsey office, together with appointed representative services from its London office.

‍

Bronwyn Alexander, Client Director at Langham Hall, said: "Closing a second fund to support a high-quality and active pipeline less than two years after a successful maiden fundraise is a remarkable achievement. We are delighted to have supported Northcote Equity across both Fund I and Fund II, and we look forward to continuing the partnership as the firm builds on these two successful closes."

‍

Matthew Charman, Co-Founder at Northcote Equity, said: "Reaching a first and final close of Fund II with both existing and new investors is a strong endorsement of our strategy and our team. Langham Hall has been a trusted partner since our launch and their support across both funds has allowed us to focus on what matters most, backing exceptional founder-owned businesses across the UK and Ireland."

‍

Northcote was also advised by Acanthus Capital, Ashurst Perkins Coie and Carey Olsen.

Langham Hall continues to support many high-profile spinouts, including PX3, bd-capital, Hypha, Atlas Health, Clipway and Goldenpeak.